Faculty profile

Srikala Sridhar

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Srikala Sridhar

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Principal investigator on 3 research grants (3 CIHR), most recently in 2018.
Supervised 1 trainee who won CIHR awards, most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Auger Electron Radiotherapy Block Copolymer Micelles Breast Cancer Docetaxel Drug Delivery Her-2 Imaging Nanotechnology

Latest papers

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.
European urology · 2026
The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.
JTO clinical and research reports · 2025

All 22 publications

Latest funding

Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
CIHR · 2023 · Co-investigator
$929,475
PREVENT GU: Prevention of thromboembolism with rivaroxaban in GU cancer patients receiving chemotherapy: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
CIHR · 2022 · Co-investigator
$424,575
TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer: a pilot RCT and process evaluation (TOPCOP3)
CIHR · 2022 · Co-investigator
$100,000

All 8 grants and awards

22 publications.

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

Mertens LS, Mellema JJ, Sridhar S, van der Heijden MS

European urology2026

DOI: 10.1016/j.eururo.2026.05.022 PMID: 42303524

The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial.

Ruicci KM, Barry A, Ye XY, Chung PW, Berlin A, Catton C, Gutierrez E, Mesci A, McPartlin A, Raman S, Winter J, Dang J, Fallah-Rad N, Kumar V, Jiang DM, Sridhar S, Helou J, Glicksman RM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

DOI: 10.1016/j.radonc.2025.111041 PMID: 40639764

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.

Alghabban A, Corke L, Katzberg H, Bril V, Barnett-Tapia C, Mason W, Alothman R, Albiruni Ryan AR, Hogg D, Sridhar S, Dhani N, Spreafico A, Eng L, Sacher A, Bradbury P, Liu G, Leighl N, Shepherd FA

JTO clinical and research reports2025

DOI: 10.1016/j.jtocrr.2024.100772 PMID: 40242666

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Winquist E, Hotte SJ, Chi K, Sridhar S, Ellard S, Ong M, Iqbal N, Salim M, Emmenegger U, Gingerich JR

Clinical Cancer Research202511 citations

DOI: 10.1158/1078-0432.ccr-24-1612

Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.

Zimmermann C, Pope A, Hannon B, Bedard PL, Rodin G, Dhani N, Li M, Herx L, Krzyzanowska MK, Howell D, Knox JJ, Leighl NB, Sridhar S, Oza AM, Lheureux S, Booth CM, Liu G, Castro JA, Swami N, Sue-A-Quan R, Rydall A, Le LW

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2023

DOI: 10.1007/s00520-023-07870-9 PMID: 37341839

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.

Fleshner NE, Sayyid RK, Hansen AR, Chin JLK, Fernandes R, Winquist E, van der Kwast T, Sweet J, Lajkosz K, Kenk M, Hersey K, Veloso R, Berlin D, Herrera-Caceres JO, Sridhar S, Moussa M, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Joshua AM

Clinical cancer research : an official journal of the American Association for Cancer Research2023

DOI: 10.1158/1078-0432.ccr-23-0731 PMID: 37439809

Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.

Navarro-Domenech I, Arulanantham S, Liu ZA, Tjong M, Kong V, Malkov V, Tadic T, Fleshner N, Kulkarni G, Zlotta AR, Catton C, Berlin A, Sridhar S, Jiang DM, Chung P, Raman S

Radiation oncology (London, England)2023

DOI: 10.1186/s13014-023-02338-w PMID: 37730609

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.

Mittal A, Al-Ezzi E, Li X, Moloney B, Wilson B, Spiliopoulou P, Sridhar S, Fallah-Rad N, Chung P, Hamilton RJ, O'malley M, Hansen AR

British journal of cancer2023

DOI: 10.1038/s41416-023-02166-5 PMID: 36859686

2023 Canadian Urological Association guideline: Genetic testing in prostate cancer

Rendon RA, Selvarajah S, Wyatt AW, Kolinsky M, Schrader KA, Fleshner NE, Kinnaird A, Merrimen J, Niazi T, Saad F

Journal of the Canadian Urological Association202317 citationsOpen Access

DOI: 10.5489/cuaj.8588 PMID: W4387341485

Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.

Peng J, Sridhar S, Siefker-Radtke AO, Selvarajah S, Jiang DM

Current treatment options in oncology2022

DOI: 10.1007/s11864-022-01009-4 PMID: 35962938

Something wrong or missing on this profile? Suggest a correction

Srikala Sridhar

Research

Latest papers

Latest funding

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial.

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.

Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.

Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.

2023 Canadian Urological Association guideline: Genetic testing in prostate cancer

Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.

Frequent collaborators

Antonio Finelli

Urban Emmenegger

Alejandro Berlin

Neesha Dhani

Geoffrey Liu

Bobby Shayegan

Madeline Li

Breffni Hannon

Eric Vigneault

Eric Winquist

Doris Howell

Stephanie Lheureux

Gary Rodin

Camilla Zimmermann

Sebastien Hotte

Lesley Seymour

Michael Kolinsky

Michael Ong

Eitan Amir

Lawson Eng

Christina Canil

Andrew Loblaw

Peter Black

Xuan Li

Ming-Sound Tsao

Girish Kulkarni

Aly-Khan Lalani

Louise Bordeleau